Clinical Trials Directory

Trials / Unknown

UnknownNCT03393234

Intersphincteric Resection With or Without Intraoperative Radiation in Rectal Cancer

Study of Safety and Feasibility of the Intersphincteric Resection With or Without Intraoperative Radiation in Low Rectal Cancer

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Second Hospital of Jilin University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study was to research on the safety and feasibility of ISR combined with low energy X ray intra-operative radiotherapy for the patients with local advanced rectal cancer.

Detailed description

Inter-sphincteric resection (ISR) has become an increasingly popular optional surgical tool for the treatment of very low rectal cancer. Nowadays, preoperative criteria for Lap ISR were the patients whose diagnosed with clinical stages T1-2 and N0\_1, which only a few patients with early stages can benefit from it. However, intra-operative radiotherapy with low energy X ray applied by Intrabeam is becoming an accepted radiotherapy technique for treatment of cancers. The purpose of this study was to research on the safety and feasibility of ISR combined with low energy X ray intra-operative radiotherapy for the patients with local advanced rectal cancer.

Conditions

Interventions

TypeNameDescription
RADIATIONInteroperative radiation by INTRABEAM using low energy X-rayIntrabeam is a mobile Platform for Intraoperative Radiotherapy (IORT) produced by the ZEISS company in Germany.Interoperative radiation by INTRABEAM using low energy X-ray.The Intrabeam PRS appears to be a safe technique for delivering IORT in rectal cancer patients.

Timeline

Start date
2017-06-01
Primary completion
2022-01-01
Completion
2022-01-01
First posted
2018-01-08
Last updated
2018-01-08

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03393234. Inclusion in this directory is not an endorsement.